SG11202105861WA - Vectors for protein manufacture - Google Patents

Vectors for protein manufacture

Info

Publication number
SG11202105861WA
SG11202105861WA SG11202105861WA SG11202105861WA SG11202105861WA SG 11202105861W A SG11202105861W A SG 11202105861WA SG 11202105861W A SG11202105861W A SG 11202105861WA SG 11202105861W A SG11202105861W A SG 11202105861WA SG 11202105861W A SG11202105861W A SG 11202105861WA
Authority
SG
Singapore
Prior art keywords
vectors
protein manufacture
protein
manufacture
Prior art date
Application number
SG11202105861WA
Other languages
English (en)
Inventor
Gregory T Bleck
Rachel H Kravitz
Chad A Hall
Original Assignee
Catalent Pharma Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Llc filed Critical Catalent Pharma Solutions Llc
Publication of SG11202105861WA publication Critical patent/SG11202105861WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202105861WA 2018-12-04 2019-12-04 Vectors for protein manufacture SG11202105861WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862775194P 2018-12-04 2018-12-04
PCT/US2019/064423 WO2020117910A1 (en) 2018-12-04 2019-12-04 Vectors for protein manufacture

Publications (1)

Publication Number Publication Date
SG11202105861WA true SG11202105861WA (en) 2021-07-29

Family

ID=70974897

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105861WA SG11202105861WA (en) 2018-12-04 2019-12-04 Vectors for protein manufacture

Country Status (11)

Country Link
US (1) US20220056476A1 (zh)
EP (1) EP3891278A4 (zh)
JP (1) JP2022510813A (zh)
KR (1) KR20210098976A (zh)
CN (1) CN113039270A (zh)
AU (1) AU2019392554A1 (zh)
BR (1) BR112021010785A2 (zh)
CA (1) CA3119799A1 (zh)
MX (1) MX2021006241A (zh)
SG (1) SG11202105861WA (zh)
WO (1) WO2020117910A1 (zh)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256568A (en) * 1990-02-12 1993-10-26 Regeneron Phamaceuticals, Inc. Vectors and transformed most cells for recombinant protein production with reduced expression of selectable markers
CA2262476C (en) * 1996-09-20 2007-05-29 Cold Spring Harbor Laboratory Viral vectors and their uses
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
AU2003303308B2 (en) * 2002-11-18 2009-07-30 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Cell lines and host nucleic acid sequences related to infectious disease
CN100429315C (zh) * 2003-03-11 2008-10-29 雪兰诺实验室有限公司 含有mcmv ie2启动子的表达载体
US7632509B2 (en) * 2005-07-19 2009-12-15 Biosante Pharmaceuticals, Inc. Methods to express recombinant proteins from lentiviral vectors
EP2325322A1 (en) * 2009-11-23 2011-05-25 4-Antibody AG Retroviral vector particles and methods for their generation and use
US20160194660A1 (en) * 2012-12-21 2016-07-07 Merck Sharp & Dohme Corp. Expression vectors for recombinant protein production in mammalian cells
KR20170081784A (ko) * 2016-01-04 2017-07-13 한국과학기술원 Gs 유전자가 결핍된 신규한 hek293 세포주 및 상기 형질전환된 hek293 숙주세포를 이용한 목적 단백질의 생산 방법
IL260369B2 (en) * 2016-01-06 2024-03-01 Lonza Ag Inhibition of protein breakdown for improved production
CN107164409B (zh) * 2017-04-17 2021-01-15 华中农业大学 犬瘟热病毒敏感细胞系slam-mdck及其构建方法和应用
KR20230019156A (ko) * 2020-06-02 2023-02-07 카탈렌트 파마 솔루션즈, 엘엘씨 유전자 삽입을 위한 다수의 도크들이 있는 세포주

Also Published As

Publication number Publication date
CN113039270A (zh) 2021-06-25
EP3891278A1 (en) 2021-10-13
US20220056476A1 (en) 2022-02-24
EP3891278A4 (en) 2022-08-31
JP2022510813A (ja) 2022-01-28
BR112021010785A2 (pt) 2021-11-16
AU2019392554A1 (en) 2021-06-03
WO2020117910A1 (en) 2020-06-11
CA3119799A1 (en) 2020-06-11
MX2021006241A (es) 2021-08-11
KR20210098976A (ko) 2021-08-11

Similar Documents

Publication Publication Date Title
GB201800903D0 (en) Vectors
DK3737402T3 (en) Modificeret protein
IL268197A (en) CSF1R-based chimeric proteins
IL277706A (en) Reprogramming vectors
IL288412A (en) peptides
IL281088A (en) FLT3L - based chimeric proteins
IL279355A (en) Antigen binding protein against STEAP1
IL268170A (en) vsig8-based chimeric proteins
ZA202102533B (en) Fusion protein
SG11202006140TA (en) Process for providing pegylated protein composition
GB201815670D0 (en) Protein editing
IL284006A (en) Mitochondria-targeted peptides
GB201810052D0 (en) Polypeptide
SG11202105861WA (en) Vectors for protein manufacture
GB201909710D0 (en) Proteins
GB201816644D0 (en) Vectors
GB201806375D0 (en) Vectors
GB201913320D0 (en) Novel proteins
GB201807863D0 (en) Peptides
GB201904756D0 (en) Novel proteins
GB201806181D0 (en) Peptides
IL290019A (en) Peptides to regulate melanocytes
GB201805807D0 (en) Peptides
GB201805801D0 (en) Peptides
GB201805809D0 (en) Peptides